NYCU and Japanese Partners Launch Five-University CP-OLED Initiative with Joint Symposium|Central News Agency
Faculty of Science and Engineering
Taiwan hosts kickoff symposium for bilateral circularly polarized light project|Bioengineer.org
Faculty of Science and Engineering
Bilateral circularly polarized light project holds kickoff symposium in Taiwan
Faculty of Science and Engineering
IL-17 identified as potential immunotherapy biomarker in ovarian cancer|Drug Target Review
Faculty of Medicine
Traditional Japanese dye shows skin-protective effects|Science Japan
Pharmaceutical Research and Technology Institute

Professor/Senior Staff
KUDO Masatoshi
Department of Medicine / Graduate School of Medical Sciences
Professor Kudo has been a member of the ILCA (International Liver Cancer Association) Governing Board since 2009 and is a past president of APPLE (Asia-Pacific Primary Liver Cancer Expert Association). He has published over 1,100 international scientific peer-reviewed papers in well-regarded journals. He received a Highly Cited Researchers award in the Clinical Medicine category from Clarivate Analytics in 2019, 2020, and 2021.

Professor/Senior Staff/Dean
NISHIO Kazuto
Department of Medicine / Graduate School of Medical Sciences
Professor Nishio's specialty is pharmacotherapy for cancer--particularly in the areas of targeted therapy, translational research, biomarkers, and personalized medicine. Using genome and gene analyses as well as approaches grounded in molecular biology, he works to elucidate pathological conditions and conducts research on biomarker development.
No.1
In Japan for number of applicants - for 11 years running
35,875
Undergraduate students
270+
Foreign partner schools in around 50 countries
Some pages linked above are in Japanese only.